Free Pharmacology Journals

High Impact List of Articles

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• Amantadine and phenytoin: patent protected cases of drug repositioning Jan M. Keppel Hesselink

  Research Article: Clinical Investigation

• New evidence supports tandem treatment in some ovarian cancers

  News and Views: Clinical Investigation

• New evidence supports tandem treatment in some ovarian cancers

  News and Views: Clinical Investigation

• New evidence supports tandem treatment in some ovarian cancers

  News and Views: Clinical Investigation

• New evidence supports tandem treatment in some ovarian cancers

  News and Views: Clinical Investigation

• New evidence supports tandem treatment in some ovarian cancers

  News and Views: Clinical Investigation

• New evidence supports tandem treatment in some ovarian cancers

  News and Views: Clinical Investigation

• New evidence supports tandem treatment in some ovarian cancers

  News and Views: Clinical Investigation

• New evidence supports tandem treatment in some ovarian cancers

  News and Views: Clinical Investigation

• Sustained and rapid virological responses in hepatitis C clinical trials Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba

  Clinical Trail Prospective: Clinical Investigation

• Sustained and rapid virological responses in hepatitis C clinical trials Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba

  Clinical Trail Prospective: Clinical Investigation

• Sustained and rapid virological responses in hepatitis C clinical trials Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba

  Clinical Trail Prospective: Clinical Investigation

• Sustained and rapid virological responses in hepatitis C clinical trials Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba

  Clinical Trail Prospective: Clinical Investigation

• Sustained and rapid virological responses in hepatitis C clinical trials Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba

  Clinical Trail Prospective: Clinical Investigation

• Sustained and rapid virological responses in hepatitis C clinical trials Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba

  Clinical Trail Prospective: Clinical Investigation

• Sustained and rapid virological responses in hepatitis C clinical trials Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba

  Clinical Trail Prospective: Clinical Investigation

• Sustained and rapid virological responses in hepatitis C clinical trials Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba

  Clinical Trail Prospective: Clinical Investigation

• Challenges in clinical trial design for recurrent glioblastoma Katharine A McNeill, Howard A Fine

  Clinical Trail Methodology: Clinical Investigation

• Challenges in clinical trial design for recurrent glioblastoma Katharine A McNeill, Howard A Fine

  Clinical Trail Methodology: Clinical Investigation

• Challenges in clinical trial design for recurrent glioblastoma Katharine A McNeill, Howard A Fine

  Clinical Trail Methodology: Clinical Investigation

• Challenges in clinical trial design for recurrent glioblastoma Katharine A McNeill, Howard A Fine

  Clinical Trail Methodology: Clinical Investigation

• Challenges in clinical trial design for recurrent glioblastoma Katharine A McNeill, Howard A Fine

  Clinical Trail Methodology: Clinical Investigation

• Challenges in clinical trial design for recurrent glioblastoma Katharine A McNeill, Howard A Fine

  Clinical Trail Methodology: Clinical Investigation

• Challenges in clinical trial design for recurrent glioblastoma Katharine A McNeill, Howard A Fine

  Clinical Trail Methodology: Clinical Investigation

• Challenges in clinical trial design for recurrent glioblastoma Katharine A McNeill, Howard A Fine

  Clinical Trail Methodology: Clinical Investigation

• Hepatitis B needle-free vaccines: a step closer Olga Borges, Gerrit Borchard

  Editorial: Clinical Investigation

• Hepatitis B needle-free vaccines: a step closer Olga Borges, Gerrit Borchard

  Editorial: Clinical Investigation

• Hepatitis B needle-free vaccines: a step closer Olga Borges, Gerrit Borchard

  Editorial: Clinical Investigation

• Hepatitis B needle-free vaccines: a step closer Olga Borges, Gerrit Borchard

  Editorial: Clinical Investigation

• Hepatitis B needle-free vaccines: a step closer Olga Borges, Gerrit Borchard

  Editorial: Clinical Investigation

• Hepatitis B needle-free vaccines: a step closer Olga Borges, Gerrit Borchard

  Editorial: Clinical Investigation

• Hepatitis B needle-free vaccines: a step closer Olga Borges, Gerrit Borchard

  Editorial: Clinical Investigation

• Hepatitis B needle-free vaccines: a step closer Olga Borges, Gerrit Borchard

  Editorial: Clinical Investigation

Relevant Topics in Clinical